XML 53 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based payments
12 Months Ended
Jun. 30, 2022
Text block [abstract]  
Share-based payments
Note 33. Share-based payments
All of the options set out below have been issued to employees and directors under the ESOP. During the financial year an expense of $1,674,581 was recognised.
2022
 
    
Number of
options
2022
    
Weighted
average
exercise price
2022
    
Number of
options
2021
    
Weighted
average
exercise price
2021
 
         
Outstanding at the beginning of the financial year
     4,219,000      $ 0.8911        2,775,167      $ 0.7970  
Granted
     4,800,000      $ 1.6110        2,200,000      $ 1.0915  
Exercised
     (25,000    $ 0.6700        (441,500    $ 0.6195  
Expired
     (338,500    $ 1.1123        (314,667    $ 1.8473  
    
 
 
             
 
 
          
Outstanding at the end of the financial year
     8,655,500      $ 1.2826        4,219,000      $ 0.8911  
    
 
 
             
 
 
          
Exercisable at the end of the financial
year
     3,180,500      $ 0.8770        2,506,667      $ 0.6195  
    
 
 
             
 
 
          
2022
 
Tranche
  
Grant date
 
  
Expiry date
 
  
Exercise
price
 
  
Balance at
the start of
the year
 
  
Granted
 
  
Exercised
 
 
Expired /
lapsed
on termination
of employment
 
 
Balance at
the end of
the year
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 
 
05/09/2016        05/09/2021      $ 1.6300        50,000        —          —         (50,000     —    
2
 
 
12/10/2016        17/10/2021      $ 1.5600        62,000        —          —         (62,000     —    
3
 
 
31/10/2016        01/11/2021      $ 1.3800        12,500        —          —         (12,500     —    
4
 
 
21/11/2016        23/11/2021      $ 1.3800        50,000        —          —         (50,000     —    
5
 
 
07/08/2017        07/08/2022      $ 0.6700        87,000        —          (25,000     (46,500     15,500  
6
 
 
05/02/2018        05/02/2023      $ 0.7800        320,000        —          —         (80,000     240,000  
7
 
 
04/01/2019        04/01/2024      $ 0.4925        37,500        —          —         (37,500     —    
8
 
 
13/11/2019        13/11/2023      $ 0.4925        1,200,000        —          —         —         1,200,000  
9
 
 
13/01/2020        13/01/2025      $ 0.8812        200,000        —          —         —         200,000  
10
 
 
09/11/2020        09/11/2024      $ 1.1320        1,200,000        —          —         —         1,200,000  
11
 
 
09/11/2020        09/11/2024      $ 0.8812        800,000        —          —         —         800,000  
12
 
 
04/01/2021        04/01/2025      $ 1.6900        200,000        —          —         —         200,000  
13
 
 
09/09/2021        21/06/2026      $ 1.3700        —          100,000        —         —         100,000  
14
 
 
16/11/2021        16/11/2025      $ 1.6900        —          1,000,000        —         —         1,000,000  
15
 
 
16/11/2021        16/11/2025      $ 2.2400        —          1,500,000        —         —         1,500,000  
16
 
 
16/11/2021        16/11/2025      $ 1.5600        —          800,000        —         —         800,000  
17
 
 
01/02/2022        01/02/2027      $ 0.9400        —          500,000        —         —         500,000  
18
 
 
01/02/2022        01/02/2027      $ 0.9400        —          800,000        —         —         800,000  
19
 
 
24/05/2022        24/05/2027      $ 0.7800        —          100,000        —         —         100,000  
 
 
 
                        
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
 
 
 
                           4,219,000        4,800,000        (25,000     (338,500     8,655,500  
 
 
 
                        
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Weighted average exercise price
$ 0.8911      $ 1.6110      $ 0.6700     $ 1.1123     $ 1.2826  
At the end of the period the following outstanding options were vested and exercisable:
- Options in tranche 1 - 4 expired during the year
- Options in tranches 1 - 8 were vested and exercisable, apart from those in the above table which have expired
- Options in tranches 9 - 10 were vested and exercisable as to 50%
- Options in tranche 11 were vested and exercisable as to 75%
- Options in tranches 12 - 14 were vested and exercisable as to 25%
- Options in tranches 15 - 19 were unvested
The weighted average remaining contractual life of options outstanding at 30 June 2022 is 3.048 years.
 
2021
 
Tranche
  
Grant date
  
Expiry date
 
  
Exercise
price
 
  
Balance at
the start of
the year
 
  
Granted
 
  
Exercised
 
 
Expired /
lapsed
on termination
of employment
 
 
Balance at
the end of
the year
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 
16/11/2015      16/11/2020      $ 2.2000        236,667        —          —         (236,667     —    
2
 
05/09/2016      05/09/2021      $ 1.6300        50,000        —          —         —         50,000  
3
 
12/10/2016      17/10/2021      $ 1.5600        62,000        —          —         —         62,000  
4
 
31/10/2016      01/11/2021      $ 1.3800        12,500        —          —         —         12,500  
5
 
21/11/2016      23/11/2021      $ 1.3800        50,000        —          —         —         50,000  
6
 
07/08/2017      07/08/2022      $ 0.6700        224,000        —          (121,500     (15,500     87,000  
7
 
05/02/2018      05/02/2023      $ 0.7800        440,000        —          (120,000     —         320,000  
8
 
04/01/2019      04/01/2024      $ 0.4925        250,000        —          (200,000     (12,500     37,500  
9
 
13/11/2019      13/11/2023      $ 0.4925        1,200,000        —          —         —         1,200,000  
10
 
13/01/2020      13/01/2025      $ 0.8812        250,000        —          —         (50,000     200,000  
11
 
09/11/2020      09/11/2024      $ 1.1320        —          1,200,000        —         —         1,200,000  
12
 
09/11/2020      09/11/2024      $ 0.8812        —          800,000        —         —         800,000  
13
 
04/01/2021      04/01/2025      $ 1.6900        —          200,000        —         —         200,000  
 
 
                      
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
 
 
                         2,775,167        2,200,000        (441,500     (314,667     4,219,000  
 
 
                      
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Weighted average exercise price
 
   $ 0.7970      $ 1.0915      $ 0.6195     $ 1.8473     $ 0.8911  
At the end of the period the following outstanding options were vested and exercisable:
- Options in tranche 1 have expired during the year
- Options in tranches 2 - 8 were vested and exercisable except for tranche 6 which was vested as to 53%
- Options in tranche 9 were vested as to 1million of the 1.2million options on issue
- Options in tranches
10-12
were 25% vested
- Options in tranche 13 were unvested at year end
The weighted average remaining contractual life of options outstanding at 30 June 2021 is 2.6 years.
Employee share options
During the year ended 30 June 2022, 4,800,000 options have been issued to directors and employees by the consolidated entity pursuant to the Company’s Employee Share Option Plan.
 
 
Tranche 14 vests as to 25% immediately on issue and then in three equal annual amounts from one year from the date of issue.
 
 
Tranches 13 & 15 - 19 vest in four equal annual amounts from one year of the date of issue
Vesting conditions for options within all tranches, is based on service period only; i.e. options will only vest if the option holder continues to be a full-time employee with the Company or an Associated Company during the vesting period relating to the option.
Conditions for an option to be exercised:
 
 
The option must have vested;
 
 
Option holder must have provided the Company with an Exercise Notice and have paid the Exercise Price for the option;
 
 
The Exercise Notice must be for the exercise of at least the Minimum Number of Options; and
 
 
The Exercise Notice must have been provided to the Company and Exercise Price paid before the expiry of 5 years from the date the Option is issued.
 
Options Valuation
In order to obtain a fair valuation of these options, the following assumptions have been made:
The Black Scholes option valuation methodology has been used with the expectation that the majority of these options would be exercised towards the end of the option term. Inputs into the Black Scholes model includes the share price at grant date, exercise price, volatility, and the risk free rate of a five year Australian Government Bond on grant date.
Risk-free rate and grant date
For all tranches, the risk-free rate of a five-year Australian Government bond on grant date was used. Please refer to the table below for details.
The abovementioned options have various vesting periods and exercising conditions. These options are unlisted as at 30 June 2022.
No dividends are expected to be declared or paid by the consolidated entity during the terms of the options.
The underlying expected volatility was determined by reference to historical data of the Company’s shares over a period of time. No special features inherent to the options granted were incorporated into measurement of fair value.
Based on the above assumptions, the table
below
sets out the valuation for each tranche of options:
 
Grant date
  
Expiry date
  
Share price at
Grant Date
  
Exercise
price
  
Volatility
(%)
 
Dividend
yield (%)
  
Risk free
Rate (%)
 
Fair value
per option
               
07/08/2017    07/08/2022    $0.4300    $0.6700    74.50%   —      1.95%   $0.206
05/02/2018    05/02/2023    $0.5000    $0.7800    74.50%   —      1.95%   $0.200
13/11/2019    13/11/2023    $0.4100    $0.4925    74.50%   —      1.95%   $0.180
13/01/2020    13/01/2025    $0.6200    $0.8812    74.50%   —      1.95%   $0.340
09/11/2020    09/11/2024    $0.8900    $1.1320    90.00%   —      0.10%   $0.413
09/11/2020    09/11/2024    $0.8900    $0.8812    90.00%   —      0.10%   $0.503
04/01/2021    04/01/2025    $1.1850    $1.6900    90.00%   —      0.19%   $0.600
09/09/2021    21/06/2026    $1.4200    $1.3700    76.00%   —      1.50%   $0.880
16/11/2021    16/11/2025    $1.5700    $1.6900    76.00%   —      1.50%   $0.850
16/11/2021    16/11/2025    $1.5700    $2.2400    76.00%   —      1.50%   $0.750
16/11/2021    16/11/2025    $1.5700    $1.5600    76.00%   —      1.50%   $0.970
01/02/2022    01/02/2027    $0.9600    $0.9400    79.00%   —      1.50%   $0.590
24/05/2022    24/05/2027    $0.8000    $0.7800    44.00%   —      2.95%   $0.630